Skip to content
10-Q

Quarterly Report

GLOBUS MEDICAL, INC. GMED

0001628280-26-032290

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 135.74M sh
Shares Diluted Q1 2026 · Mar 31, 2026 138.19M sh
Shares Diluted Q1 2026 · Mar 31, 2025 139.77M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $190.45M
Capex Q1 2026 · Mar 31, 2026 $39.62M
Capex Q1 2026 · Mar 31, 2025 $36.1M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $202.36M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $177.3M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $560.95M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $526.16M
Stockholders Equity Q1 2026 · Mar 31, 2026 $4.73B
Stockholders Equity Q1 2026 · Dec 31, 2025 $4.57B
Stockholders Equity Q1 2026 · Mar 31, 2025 $4.09B
Stockholders Equity Q1 2026 · Dec 31, 2024 $4.18B
Current Liabilities Q1 2026 · Mar 31, 2026 $482.46M
Current Liabilities Q1 2026 · Dec 31, 2025 $498.5M
Total Liabilities Q1 2026 · Mar 31, 2026 $707.24M
Total Liabilities Q1 2026 · Dec 31, 2025 $729.51M
Current Assets Q1 2026 · Mar 31, 2026 $2.2B
Current Assets Q1 2026 · Dec 31, 2025 $2.13B
Total Assets Q1 2026 · Mar 31, 2026 $5.44B
Total Assets Q1 2026 · Dec 31, 2025 $5.3B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.90
Eps Diluted Q1 2026 · Mar 31, 2025 $0.54
Eps Basic Q1 2026 · Mar 31, 2026 $0.92
Eps Basic Q1 2026 · Mar 31, 2025 $0.55
Sga Expense Q1 2026 · Mar 31, 2026 $297.78M
Sga Expense Q1 2026 · Mar 31, 2025 $242.8M
Rd Expense Q1 2026 · Mar 31, 2026 $36.51M
Rd Expense Q1 2026 · Mar 31, 2025 $33.06M
Net Income Q1 2026 · Mar 31, 2026 $124.3M
Net Income Q1 2026 · Mar 31, 2025 $75.46M
Operating Income Q1 2026 · Mar 31, 2026 $150.39M
Operating Income Q1 2026 · Mar 31, 2025 $97M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $234.07M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $195.4M
Revenue Q1 2026 · Mar 31, 2026 $759.85M
Revenue Q1 2026 · Mar 31, 2025 $598.12M